Involvement of Rho GTPases and their regulators in the pathogenesis of hypertension

Small GTPases

Volumn 5, Issue 4, 2014, Pages

  Loirand, Gervaise ^a,b,c   Pacaud, Pierre ^a,b,c  

^a L INSTITUT DU THORAX   (France)

^b CNRS U6291   (France)

^c UNIVERSITÉ DE NANTES   (France)

Author keywords

Artery; Blood pressure; Cardiovascular; Exchange factors; GTPase activating proteins; GTPases; Signal transduction; Small G proteins; Smooth muscle; Vasoconstriction

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPITHELIAL SODIUM CHANNEL; RAC1 PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CENTRAL NERVOUS SYSTEM; GENETIC ASSOCIATION; HUMAN; HYPERTENSION; KIDNEY FUNCTION; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SALT LOADING; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE;

EID: 84922210788     PISSN: 21541248     EISSN: 21541256     Source Type: Journal    
DOI: 10.4161/sgtp.28846     Document Type: Article

References (88)

1. Puetz S, Lubomirov LT, Pfitzer G. Regulation of smooth muscle contraction by small GTPases. Physiology (Bethesda) 2009; 24:342-56; PMID:19996365; http://dx.doi.org/10.1152/physiol.00023.2009
2. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997; 389:990-4; PMID:9353125; http://dx.doi.org/10.1038/40187
3. Wang Y, Zheng XR, Riddick N, Bryden M, Baur W, Zhang X, Surks HK. ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells. Circ Res 2009; 104:531-40; PMID:19131646; http://dx.doi.org/10.1161/ CIRCRESAHA.108.188524
4. Somlyo AP, Somlyo AV. Ca2C sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 2003; 83:1325-58; PMID:14506307
5. Loirand G, Guerin P, Pacaud P. Rho kinases in cardio-vascular physiology and pathophysiology. Circ Res 2006; 98:322-34; PMID:16484628; http://dx.doi.org/10.1161/01.RES.0000201960.04223.3c
6. Wheeler AP, Ridley AJ. Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility. Exp Cell Res 2004; 301:43-9; PMID:15501444; http://dx.doi.org/10.1016/j.yexcr.2004.08.012
7. Wojciak-Stothard B, Zhao L, Oliver E, Dubois O, Wu Y, Kardassis D, Vasilaki E, Huang M, Mitchell JA, Harrington LS, et al. Role of RhoB in the regulation of pulmonary endothelial and smooth muscle cell responses to hypoxia. Circ Res 2012; 110:1423-34; PMID:22539766; http://dx.doi.org/10.1161/CIRCRESAHA.112.264473
8. Huang M, Duhadaway JB, Prendergast GC, Laury-Kleintop LD, Rho B. RhoB regulates PDGFR-beta trafficking and signaling in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2007; 27:2597-605; PMID:17951322; http://dx.doi.org/10.1161/ATVBAHA.107.154211
9. Shirai H, Autieri M, Eguchi S. Small GTP-binding proteins and mitogen-activated protein kinases as promising therapeutic targets of vascular remodeling. Curr Opin Nephrol Hypertens 2007; 16:111-5; PMID:17293685; http://dx.doi.org/10.1097/MNH.0b013e3280148e4f
10. Sanders LC, Matsumura F, Bokoch GM, de Lanerolle P. Inhibition of myosin light chain kinase by p21-activated kinase. Science 1999; 283:2083-5; PMID: 10092231; http://dx.doi.org/10.1126/science.283. 5410.2083
11. Wirth A, Schroeter M, Kock-Hauser C, Manser E, Chalovich JM, De Lanerolle P, Pfitzer G. Inhibition of contraction and myosin light chain phosphorylation in guinea-pig smooth muscle by p21-activated kinase 1. J Physiol 2003; 549:489-500; PMID:12692179; http://dx.doi.org/10.1113/jphysiol.2002.033167
12. Foster DB, Shen LH, Kelly J, Thibault P, Van Eyk JE, Mak AS. Phosphorylation of caldesmon by p21-activated kinase. Implications for the Ca(2C) sensitivity of smooth muscle contraction. J Biol Chem 2000; 275:1959-65; PMID:10636898; http://dx.doi.org/10.1074/jbc.275.3.1959
13. Rahman A, Davis B, Lovdahl C, Th V, Feil R, Brake-busch C, et al. The small GTPase Rac1 is required for smooth muscle contraction. J Physiol 2014; 592:915-26; PMID:24297853; http://dx.doi.org/10.1113/jphysiol.2013.262998
14. Loirand G, Pacaud P. The role of Rho protein signaling in hypertension. Nat Rev Cardiol 2010; 7:637-47; PMID:20808285; http://dx.doi.org/10.1038/nrcardio2010.136
15. Sauzeau V, Le Jeune H, Cario-Toumaniantz C, Smolenski A, Lohmann SM, Bertoglio J, Chardin P, Pacaud P, Loirand G. Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2C sensitization of contraction in vascular smooth muscle. J Biol Chem 2000; 275:21722-9; PMID:10783386; http://dx.doi.org/10.1074/jbc.M000753200
16. Sauzeau V, Sevilla MA, Montero MJ, Bustelo XR. The Rho/Rac exchange factor Vav2 controls nitric oxide-dependent responses in mouse vascular smooth muscle cells. J Clin Invest 2010; 120:315-30; PMID: 20038798; http://dx.doi.org/10.1172/JCI38356
17. Laufs U, Liao JK. Post-transcriptional regulation of ndothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 1998; 273:24266-71; PMID:9727051; http://dx.doi.org/10.1074/jbc.273.37.24266
18. Zhou Q, Liao JK. Rho kinase: an important mediator of atherosclerosis and vascular disease. Curr Pharm Des 2009; 15:3108-15; PMID:19754385; http://dx.doi.org/10.2174/138161209789057986
19. Wolfrum S, Dendorfer A, Rikitake Y, Stalker TJ, Gong Y, Scalia R, Dominiak P, Liao JK. Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol 2004; 24:1842-7; PMID:15319269; http://dx.doi.org/10.1161/01.ATV.0000142813.33538.82
20. Ming XF, Barandier C, Viswambharan H, Kwak BR, Mach F, Mazzolai L, Hayoz D, Ruffieux J, Rusconi S, Montani JP, et al. Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: implications for atherosclerotic endothelial dysfunction. Circulation 2004; 110:3708-14;PMID:15569838; http://dx.doi.org/10.1161/01.CIR.0000142867.26182.32
21. Sawada N, Salomone S, Kim HH, Kwiatkowski DJ, Liao JK. Regulation of endothelial nitric oxide synthase and postnatal angiogenesis by Rac1. Circ Res 2008; 103:360-8; PMID:18599867; http://dx.doi.org/10.1161/CIRCRESAHA.108.178897
22. Selvakumar B, Hess DT, Goldschmidt-Clermont PJ, Stamler JS. Co-regulation of constitutive nitric oxide synthases and NADPH oxidase by the small GTPase Rac. FEBS Lett 2008; 582:2195-202; PMID: 18501711; http://dx.doi.org/10.1016/j.febslet.2008.04.062
23. Mukai Y, Shimokawa H, Matoba T, Kandabashi T, Satoh S, Hiroki J, Kaibuchi K, Takeshita A. Involve-ment of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension. FASEB J 2001; 15:1062-4; PMID:11292668
24. Kumai T, Takeba Y, Matsumoto N, Nakaya S, Tsuzuki Y, Yanagida Y, Hayashi M, Kobayashi S. Fasudil attenuates sympathetic nervous activity in the adrenal medulla of spontaneously hypertensive rats. Life Sci 2007; 81:1193-8; PMID:17889905; http://dx.doi.org/10.1016/j.lfs.2007.08.008
25. Lohn M, Plettenburg O, Ivashchenko Y, Kannt A, Hof-meister A, Kadereit D, Schaefer M, Linz W, Kohlmann M, Herbert JM, et al. Pharmacological characterization of SAR407899, a novel rho-kinase inhibitor. Hypertension 2009; 54:676-83; PMID:19597037; http://dx.doi.org/10.1161/HYPERTENSIONAHA.109.134353
26. Kataoka C, Egashira K, Inoue S, Takemoto M, Ni W, Koyanagi M, Kitamoto S, Usui M, Kaibuchi K, Shimokawa H, et al. Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats. Hypertension 2002; 39:245-50; PMID:11847192; http://dx.doi.org/10.1161/hy0202. 103271
27. Seko T, Ito M, Kureishi Y, Okamoto R, Moriki N, Onishi K, Isaka N, Hartshorne DJ, Nakano T. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle. Circ Res 2003; 92:411-8; PMID:12600888; http://dx.doi.org/10.1161/01.RES. 0000059987.90200.44
28. Higashi M, Shimokawa H, Hattori T, Hiroki J, Mukai Y, Morikawa K, Ichiki T, Takahashi S, Takeshita A. Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Circ Res 2003; 93:767-75; PMID:14500337;
29. http://x.doi.org/10.1161/01.RES.0000096650.91688.28
30. Kanda T, Hayashi K, Wakino S, Homma K, Yoshioka K, Hasegawa K, Sugano N, Tatematsu S, Takamatsu I, Mitsuhashi T, et al. Role of Rho-kinase and p27 in angiotensin II-induced vascular injury. Hypertension 2005; 45:724-9; PMID:15699465; http://dx.doi.org/10.1161/01.HYP.0000153316.59262.79
31. Ishimaru K, Ueno H, Kagitani S, Takabayashi D, Takata M, Inoue H. Fasudil attenuates myocardial fibrosis in association with inhibition of monocyte/ macrophage infiltration in the heart of DOCA/salt hypertensive rats. J Cardiovasc Pharmacol 2007; 50:187-94; PMID:17703135; http://dx.doi.org/10.1097/FJC.0b013e318064f150
32. Seasholtz TM, Zhang T, Morissette MR, Howes AL, Yang AH, Brown JH. Increased expression and activity of RhoA are associated with increased DNA synthesis and reduced p27(Kip1) expression in the vasculature of hypertensive rats. Circ Res 2001; 89:488-95; PMID:11557735; http://dx.doi.org/10.1161/hh1801. 096337
33. Guilluy C, Bregeon J, Toumaniantz G, Rolli-Derkinderen M, Retailleau K, Loufrani L, Henrion D, Scal-bert E, Bril A, Torres RM, et al. The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure. Nat Med 2010; 16:183-90; PMID:20098430; http://dx.doi.org/10.1038/nm.2079
34. Rikitake Y, Oyama N, Wang CY, Noma K, Satoh M, Kim HH, Liao JK. Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1C/haploinsufficient mice. Circulation 2005; 112:2959-65; PMID:16260635
35. Zhang YM, Bo J, Taffet GE, Chang J, Shi J, Reddy AK,Michael LH, Schneider MD, Entman ML, Schwartz RJ, et al. Targeted deletion of ROCK1 protects the heart against pressure overload by inhibiting reactive fibrosis. FASEB J 2006; 20:916-25; PMID:16675849; http://dx.doi.org/10.1096/fj.05-5129com
36. Hilgers RH, Todd J Jr., Webb RC. Increased PDZRhoGEF/RhoA/Rho kinase signaling in small mesenteric arteries of angiotensin II-induced hypertensive rats. J Hypertens 2007; 25:1687-97; PMID:17620967; http://dx.doi.org/10.1097/HJH.0b013e32816f778d
37. Jin L, Ying Z, Hilgers RH, Yin J, Zhao X, Imig JD, Webb RC. Increased RhoA/Rho-kinase signaling mediates spontaneous tone in aorta from angiotensin II-induced hypertensive rats. J Pharmacol Exp Ther 2006; 318:288-95; PMID:16569756; http://dx.doi.org/10.1124/jpet.105.100735
38. Ying Z, Jin L, Dorrance AM, Webb RC. Increaseed expression of mRNA for regulator of G protein signaling domain-containing Rho guanine nucleotide exchange factors in aorta from stroke-prone spontaneously hypertensive rats. Am J Hypertens 2004; 17:981-5; PMID:15485764; http://dx.doi.org/10.1016/j.amjhyper.2004.05.006
39. Wirth A, Benyo Z, Lukasova M, Leutgeb B, Wettschureck N, Gorbey S, Orsy P, Horvath B, Maser-Gluth C, Greiner E, et al. G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt induced hypertension. Nat Med 2008; 14:64-8; PMID:18084302; http://dx.doi.org/10.1038/nm1666
40. Momotani K, Artamonov MV, Utepbergenov D, Dere-wenda U, Derewenda ZS, Somlyo AV. p63RhoGEF couples Ga(q/11)-mediated signaling to Ca2C sensitization of vascular smooth muscle contractility. Circ Res 2011; 109:993-1002; PMID:21885830; http://dx.doi.org/10.1161/CIRCRESAHA.111.248898
41. Cario-Toumaniantz C, Ferland-McCollough D, Cha-deuf G, Toumaniantz G, Rodriguez M, Galizzi JP, Lockhart B, Bril A, Scalbert E, Loirand G, et al. RhoA guanine exchange factor expression profile in arteries: evidence for a Rho kinase-dependent negative feedback in angiotensin II-dependent hypertension. Am J Physiol Cell Physiol 2012; 302:C1394-404; PMID: 22322975; http://dx.doi.org/10.1152/ajpcell.00423.2011
42. Wuertz CM, Lorincz A, Vettel C, Thomas MA, Wieland T, Lutz S. p63RhoGEF-a key mediator of angiotensin II-dependent signaling and processes in vascular smooth muscle cells. FASEB J 2010; 24:4865-76; PMID:20739613; http://dx.doi.org/10.1096/fj.10-155499
43. Ying Z, Giachini FR, Tostes RC, Webb RC. PYK2/PDZ-RhoGEF links Ca2 Csignaling to RhoA. Arterioscler Thromb Vasc Biol 2009; 29:1657-63; PMID:19759375; http://dx.doi.org/10.1161/ATVBAHA.109.190892
44. Bear MD, Li M, Liu Y, Giel-Moloney MA, Fanburg BL, Toksoz D. The Lbc Rho guanine nucleotide exchange factor a-catulin axis functions in serotonin-induced vascular smooth muscle cell mitogenesis and RhoA/ROCK activation. J Biol Chem 2010; 285:32919-26; PMID:20696764; http://dx.doi.org/10.1074/jbc.M109.062513
45. Medlin MD, Staus DP, Dubash AD, Taylor JM, Mack CP. Sphingosine 1-phosphate receptor 2 signals through leukemia-associated RhoGEF (LARG), to promote smooth muscle cell differentiation. Arterioscler Thromb Vasc Biol 2010; 30:1779-86; PMID: 20702813; http://dx.doi.org/10.1161/ATVBAHA. 110.209395
46. Artamonov MV, Momotani K, Stevenson A, Trentham DR, Derewenda U, Derewenda ZS, Read PW, Gut-kind JS, Somlyo AV. Agonist-induced Ca2C sensitization in smooth muscle: redundancy of Rho guanine nucleotide exchange factors (RhoGEFs) and response kinetics, a caged compound study. J Biol Chem 2013; 288:34030-40; PMID:24106280; http://dx.doi.org/10.1074/jbc.M113.514596
47. Bregeon J, Loirand G, Pacaud P, Rolli-Derkinderen M. Angiotensin II induces RhoA activation through SHP2-dependent dephosphorylation of the RhoGAP p190A in vascular smooth muscle cells. Am J Physiol Cell Physiol 2009; 297:C1062-70; PMID:19692654; http://dx.doi.org/10.1152/ajpcell.00174.2009
48. Mori K, Amano M, Takefuji M, Kato K, Morita Y, Nishioka T, Matsuura Y, Murohara T, Kaibuchi K. Rho-kinase contributes to sustained RhoA activation through phosphorylation of p190A RhoGAP. J Biol Chem 2009; 284:5067-76; PMID:19103606; http://dx.doi.org/10.1074/jbc.M806853200
49. Bai X, Lenhart KC, Bird KE, Suen AA, Rojas M, Kakoki M, Li F, Smithies O, Mack CP, Taylor JM. The smooth muscle-selective RhoGAP GRAF3 is a critical regulator of vascular tone and hypertension. Nat Commun 2013; 4:2910; PMID:24335996; http://dx.doi.org/10.1038/ncomms3910
50. Rashid M, Tawara S, Fukumoto Y, Seto M, Yano K, Shimokawa H. Importance of Rac1 signaling pathway inhibition in the pleiotropic effects of HMG-CoA reductase inhibitors. Circ J 2009; 73:361-70; PMID:19060417; http://dx.doi.org/10.1253/circj.CJ-08-0817
51. Sawada N, Li Y, Liao JK. Novel aspects of the roles of Rac1 GTPase in the cardiovascular system. Curr Opin Pharmacol 2010; 10:116-21; PMID:20060361; http://dx.doi.org/10.1016/j.coph.2009.11.004
52. Vecchione C, Carnevale D, Di Pardo A, Gentile MT, Damato A, Cocozza G, Antenucci G, Mascio G, Bettarini U, Landolfi A, et al. Pressure-induced vascular oxidative stress is mediated through activation of integrin-linked kinase 1/betaPIX/Rac-1 pathway. Hypertension 2009; 54:1028-34; PMID:19770407; http://dx.doi.org/10.1161/HYPERTENSIONAHA.109.136572
53. Hassanain HH, Gregg D, Marcelo ML, Zweier JL, Souza HP, Selvakumar B, Ma Q, Moustafa-Bayoumi M, Binkley PF, Flavahan NA, et al. Hypertension caused by transgenic overexpression of Rac1. Antioxid Redox Signal 2007; 9:91-100; PMID:17115888; http://dx.doi.org/10.1089/ars.2007.9.91
54. Sauzeau V, Sevilla MA, Rivas-Elena JV, de Alava E, Montero MJ, Lopez-Novoa JM, Bustelo XR. Vav3 proto-oncogene deficiency leads to sympathetic hyperactivity and cardiovascular dysfunction. Nat Med 2006; 12:841-5; PMID:16767097; http://dx.doi.org/10.1038/nm1426
55. Pilowsky PM, Goodchild AK. Baroreceptor reflex pathways and neurotransmitters: 10 years on. J Hypertens 2002; 20:1675-88; PMID:12195099; http://dx.doi.org/10.1097/00004872-200209000-00002
56. Struthers AD, Dollery CT. Central nervous system mechanisms in blood pressure control. Eur J Clin Pharmacol 1985; 28:3-11; PMID:2865146; http://dx.doi.org/10.1007/BF00543703
57. Ito K, Hirooka Y, Sakai K, Kishi T, Kaibuchi K, Shimokawa H, Takeshita A. Rho/Rho-kinase pathway in brain stem contributes to blood pressure regulation via sympathetic nervous system: possible involvement in neural mechanisms of hypertension. Circ Res 2003; 92:1337-43; PMID:12791705; http://dx.doi.org/10.1161/01.RES.0000079941.59846.D4
58. Ito K, Hirooka Y, Kimura Y, Shimokawa H, Takeshita A. Effects of hydroxyfasudil administered to the nucleus tractus solitarii on blood pressure and heart rate in spontaneously hypertensive rats. Clin Exp Hypertens 2005; 27:269-77; PMID:15835390; http://dx.doi.org/10.1081/CEH-48876
59. Nozoe M, Hirooka Y, Koga Y, Sagara Y, Kishi T, Engelhardt JF, Sunagawa K. Inhibition of Rac1-derived reactive oxygen species in nucleus tractus solitarius decreases blood pressure and heart rate in stroke-prone spontaneously hypertensive rats. Hypertension 2007; 50:62-8; PMID:17515454; http://dx.doi.org/10.1161/ HYPERTENSIONAHA.107.087981
60. Zimmerman MC, Dunlay RP, Lazartigues E, Zhang Y, Sharma RV, Engelhardt JF, Davisson RL. Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ Res 2004; 95:532-9; PMID:15271858; http://dx.doi.org/10.1161/01.RES.0000139957.22530.b9
61. Sagara Y, Hirooka Y, Nozoe M, Ito K, Kimura Y, Sunagawa K. Pressor response induced by central angiotensin II is mediated by activation of Rho/Rhokinase pathway via AT1 receptors. J Hypertens 2007; 25:399-406; PMID:17211247; http://dx.doi.org/10.1097/HJH.0b013e328010b87f
62. Staruschenko A, Nichols A, Medina JL, Camacho P, Zheleznova NN, Stockand JD. Rho small GTPases activate the epithelial Na(C) channel. J Biol Chem 2004; 279:49989-94; PMID:15448132; http://dx.doi. org/10.1074/jbc.M409812200
63. Pochynyuk O, Medina J, Gamper N, Genth H, Stock-and JD, Staruschenko A. Rapid translocation and insertion of the epithelial NaC channel in response to RhoA signaling. J Biol Chem 2006; 281:26520-7; PMID:16829523; http://dx.doi.org/10.1074/jbc. M603716200
64. Karpushev AV, Ilatovskaya DV, Pavlov TS, Negulyaev YA, Staruschenko A. Intact cytoskeleton is required for small G protein dependent activation of the epithelial NaC channel. PLoS One 2010; 5:e8827; PMID:20098689; http://dx.doi.org/10.1371/journal.pone.0008827
65. Nishikimi T, Akimoto K, Wang X, Mori Y, Tadokoro K, Ishikawa Y, Shimokawa H, Ono H, Matsuoka H. Fasudil, a Rho-kinase inhibitor, attenuates glomerulosclerosis in Dahl salt-sensitive rats. J Hypertens 2004; 22:1787-96; PMID:15311108; http://dx.doi.org/10.1097/00004872-200409000-00024
66. Pavlov TS, Chahdi A, Ilatovskaya DV, Levchenko V, Vandewalle A, Pochynyuk O, Sorokin A, Staruschenko A. Endothelin-1 inhibits the epithelial NaC channel through betaPix/14-3-3/Nedd4-2. J Am Soc Nephrol 2010; 21:833-43; PMID:20338996; http://dx.doi.org/10.1681/ASN.2009080885
67. Karpushev AV, Levchenko V, Ilatovskaya DV, Pavlov TS, Staruschenko A. Novel role of Rac1/WAVE signaling mechanism in regulation of the epithelial NaC channel. Hypertension 2011; 57:996-1002; PMID:21464391; http://dx.doi.org/10.1161/HYPERTENSIONAHA.110.157784
68. Fujita T. Mineralocorticoid receptors, salt-sensitive hypertension, and metabolic syndrome. Hypertension 2010; 55:813-8; PMID:20176994; http://dx.doi.org/10.1161/HYPERTENSIONAHA.109.149062
69. Shibata S, Mu S, Kawarazaki H, Muraoka K, Ishizawa K, Yoshida S, Kawarazaki W, Takeuchi M, Ayuzawa N, Miyoshi J, et al. Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway. J Clin Invest 2011; 121:3233-43; PMID:21765214; http://dx.doi. org/10.1172/JCI43124
70. Shibata S, Nagase M, Yoshida S, Kawarazaki W, Kurihara H, Tanaka H, Miyoshi J, Takai Y, Fujita T. Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat Med 2008; 14:1370-6; PMID:19029984; http://dx.doi.org/10.1038/nm.1879
71. Hayashi H, Szaszi K, Coady-Osberg N, Furuya W, Bretscher AP, Orlowski J, Grinstein S. Inhibition and redistribution of NHE3, the apical NaC/HC exchanger, by Clostridium difficile toxin B. J Gen Physiol 2004; 123:491-504; PMID:15078917; http://dx.doi.org/10.1085/jgp.200308979
72. Szaszi K, Kurashima K, Kapus A, Paulsen A, Kaibuchi K, Grinstein S, Orlowski J. RhoA and rho kinase regulate the epithelial NaC/HC exchanger NHE3. Role of myosin light chain phosphorylation. J Biol Chem 2000; 275:28599-606; PMID:10893221; http://dx.doi.org/10.1074/jbc.M001193200
73. Nishiki K, Tsuruoka S, Kawaguchi A, Sugimoto K, Schwartz GJ, Suzuki M, Imai M, Fujimura A. Inhibition of Rho-kinase reduces renal Na-H exchanger activity and causes natriuresis in rat. J Pharmacol Exp Ther 2003; 304:723-8; PMID:12538827; http://dx.doi.org/10.1124/jpet.102.041871
74. Seasholtz TM, Wessel J, Rao F, Rana BK, Khandrika S, Kennedy BP, Lillie EO, Ziegler MG, Smith DW, Schork NJ, et al. Rho kinase polymorphism influences blood pressure and systemic vascular resistance in human twins: role of heredity. Hypertension 2006; 47:937-47; PMID:16585408; http://dx.doi.org/10.1161/01.HYP.0000217364.45622.f0
75. Angius A, Petretto E, Maestrale GB, Forabosco P, Casu G, Piras D, Fanciulli M, Falchi M, Melis PM, Palermo M, et al. A new essential hypertension susceptibility locus on chromosome 2p24-p25, detected by genome wide search. Am J Hum Genet 2002; 71:893-905; PMID:12228842; http://dx.doi.org/10.1086/342929
76. Rankinen T, Church T, Rice T, Markward N, Blair SN, Bouchard C. A major haplotype block at the rho associated kinase 2 locus is associated with a lower risk of hypertension in a recessive manner: the HYPGENE study. Hypertens Res 2008; 31:1651-7; PMID: 18971541; http://dx.doi.org/10.1291/hypres.31.1651
77. Liu L, Cao Y, Cui G, Li Z, Sun J, Zhang L, Chen C, Wang Y, Wang P, Ding H, et al. Association analysis of polymorphisms in ROCK2 with cardiovascular dis ease in a Chinese population. PLoS One 2013; 8: e53905; PMID:23326532; http://dx.doi.org/10.1371/journal.pone.0053905
78. Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, Coin L, Najjar SS, Zhao JH, Heath SC, Eyheramendy S, et al.; Wellcome Trust Case Control Consortium. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 2009; 41:666-76; PMID:19430483; http://dx.doi.org/10.1038/ng.361
79. Boyden LM, Choi M, Choate KA, Nelson-Williams CJ, Farhi A, Toka HR, Tikhonova IR, Bjornson R, Mane SM, Colussi G, et al. Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature 2012; 482:98-102; PMID:22266938; http://dx.doi.org/10.1038/nature10814
80. Pelham CJ, Ketsawatsomkron P, Groh S, Grobe JL, de Lange WJ, Ibeawuchi SR, Keen HL, Weatherford ET, Faraci FM, Sigmund CD. Cullin-3 regulates vascular smooth muscle function and arterial blood pressure via PPARg and RhoA/Rho-kinase. Cell Met b 2012; 16:462-72; PMID:23040068; http://dx.doi.org/10.1016/j.cmet.2012.08.011
81. Takefuji M, Asano H, Mori K, Amano M, Kato K, Watanabe T, Morita Y, Katsumi A, Itoh T, Takenawa T, et al. Mutation of ARHGAP9 in patients with coronary spastic angina. J Hum Genet 2010; 55:42-9; PMID:19911011; http://dx.doi.org/10.1038/jhg. 2009.120
82. Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI, Smith AV, Tobin MD, Verwoert GC, Hwang SJ, et al.; International Consortium for Blood Pressure Genome-Wide Association Studies; CARDIoGRAM consortium; CKDGen Consortium; KidneyGen Consortium; EchoGen consortium; CHARGE-HF consortium. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011; 478:103-9; PMID: 21909115; http://dx.doi.org/10.1038/nature10405
83. Wain LV, Verwoert GC, O’Reilly PF, Shi G, Johnson T, Johnson AD, Bochud M, Rice KM, Henneman P, Smith AV, et al.; LifeLines Cohort Study; EchoGen consortium; AortaGen Consortium; CHARGE Consortium Heart Failure Working Group; KidneyGen consortium; CKDGen consortium; Cardiogenics consortium; CardioGram. Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet 2011; 43:1005-11; PMID:21909110; http://dx.doi.org/10.1038/ng.922
84. Masumoto A, Hirooka Y, Shimokawa H, Hironaga K, Setoguchi S, Takeshita A. Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans. Hypertension 2001; 38:1307-1310; PMID: 11751708; http://dx.doi.org/10.1161/hy1201.096541
85. Kishi T, Hirooka Y, Masumoto A, Ito K, Kimura Y, Inokuchi K, Tagawa T, Shimokawa H, Takeshita A, Sunagawa K. Rho-kinase inhibitor improves increased vascular resistance and impaired vasodilation of the forearm in patients with heart failure. Circulation 2005; 111:2741-2747; PMID:15927989; http://dx.doi.org/10.1161/CIRCULATIONAHA.104.510248
86. Hata T, Goto C, Soga J, Hidaka T, Fujii Y, Idei N, Fujimura N, Maruhashi T, Mikami S, Kihara Y, et al. Measurement of Rho-associated kinase (ROCK) activity in humans: validity of leukocyte p-MBS/t-MBS in comparison with vascular response to fasudil. Atherosclerosis 2011; 214:117-221; PMID:21035804; http://dx.doi.org/10.1016/j.atherosclerosis.2010.10.005
87. Hata T, Soga J, Hidaka T, Idei N, Fujii Y, Fujimura N, Mikami S, Maruhashi T, Kihara Y, Chayama K, et al.; ROCK Study Group. Calcium channel blocker and Rhoassociated kinase activity in patients with hypertension. J Hypertens 2011; 29:373-379; PMID:21063203; http://dx.doi.org/10.1097/HJH.0b013e328340902d
88. Hung M-J, Cherng W-J, Hung M-Y, Kuo L-T, Cheng C-W, Wang C-H, Yang NI, Liao JK. Increased leukocyte Rho-associated coiled-coil containing protein kinase activity predicts the presence and severity of coronary vasospastic angina. Atherosclerosis 2012; 221:521-526; PMID:22293227; http://dx.doi.org/10.1016/j.atherosclerosis.2012.01.001